It's hard to believe we reached the end of the project in July 2022. Our final newsletter is now out, with an update on our most recent publications and dissemination activities. You can also read about our last consortium meeting in Copenhagen, including the parting thoughts of our public patient involvement (PPI) volunteers.
"AIFM1 beyond cell death: An overview of this OXPHOSinducing factor in mitochondrial diseases," an open-access review article prepared by Lena Wischhof, Enzo Scifo, Dan Ehninger and our PD-MitoQUANT PI Daniele Bano was published in eBioMedicine, part of The Lancet Discovery Science on August 18th, 2022. The research team is based at the German Center for Neurodegenerative Diseases (DZNE), in Bonn, Germany. DOI: https://doi.org/10.1016/j.ebiom.2022.104231 Summary: Apoptosis-inducing factor (AIF) is a mitochondrial intermembrane space flavoprotein with diverse functions in cellular physiology. In this [...]